...
首页> 外文期刊>Human Immunology: Official Journal of the American Society for Histocompatibility and Immunogenetics >Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma
【24h】

Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma

机译:T和B淋巴细胞活化和粘附的细胞表面标志物作为头颈部鳞状细胞癌的预后生物标志物

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The study population comprised HNSCC patients, risk-positive controls (tabagism and alcoholism habits), and risk-negative controls (without risk factors). Significant increases in the activation status of CD4+and CD8+ T-cells, and higher migration potentials of lymphocytes were observed in HNSCC patients compared with control groups. Although decreased frequency of CD19+-B lymphocytes was observed in HSNCC patients, a higher percentage of HLA-DR+CD19+-B lymphocytes was detected in these individuals as compared with other evaluated groups. Metastasis and tumor grading were the major pathological parameters associated with significant alterations in the expression of activation molecules on circulating CD4+ and CD8+ T-cells. A reduced frequency of CD38-expressing CD8+ T-cells was the most relevant biomarker associated with HNSCC aggressiveness. Performance analysis suggested a cut-off point for the CD8+CD38+/CD8+ T-cell ratio of 7.0 for segregating patients according to tumor grading. In contrast, a higher proportion of CD8+CD54+/CD8+ T-cells could represent a relevant biomarker associated with metastasis in HNSCC patients, and performance analysis suggested a cut-off point for the CD8+CD54+/CD8+ T-cell ratio of 30 for segregating patients according to absence or presence of metastasis. The results obtained can increment immunological aspects of HNSCC and provide tools for the determination of cut-off scores of clinically relevant immunophenotypic prognostic biomarkers.
机译:研究人群包括HNSCC患者,风险阳性对照(低血糖和酗酒习惯)和风险阴性对照(无危险因素)。与对照组相比,HNSCC患者中CD4 +和CD8 + T细胞的激活状态显着增加,并且淋巴细胞迁移潜力更高。尽管在HSNCC患者中观察到CD19 + -B淋巴细胞的频率降低,但与其他评估组相比,在这些个体中检测到更高百分比的HLA-DR + CD19 + -B淋巴细胞。转移和肿瘤分级是与循环CD4 +和CD8 + T细胞上活化分子表达显着改变相关的主要病理学参数。表达CD38的CD8 + T细胞频率降低是与HNSCC侵袭性最相关的生物标志物。性能分析表明,根据肿瘤分级,隔离患者的CD8 + CD38 + / CD8 + T细胞比率的临界点为7.0。相比之下,较高比例的CD8 + CD54 + / CD8 + T细胞可能代表与HNSCC患者转移相关的生物标志物,而性能分析表明CD8 + CD54 + / CD8 + T细胞的临界点为30%。根据是否存在转移将患者隔离。获得的结果可以增加HNSCC的免疫学方面,并为确定临床相关的免疫表型预后生物标志物的临界值提供工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号